Shandong Tumor Hospital
Clinical trials sponsored by Shandong Tumor Hospital, explained in plain language.
-
New hope for advanced stomach cancer: drug combo targets patients who failed first-line therapy
Disease control Recruiting nowThis study tests a combination of two drugs, carilizumab and albumin paclitaxel, as a second treatment for people with advanced stomach cancer. It includes 40 adults aged 18-75 who have already tried one prior treatment, with or without immunotherapy. The goal is to see if this c…
Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Triple-Drug cocktail aims to extend life in tough stomach cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding two drugs (adebrelimab and famitinib) to standard chemotherapy (irinotecan) can help people with advanced stomach or gastroesophageal junction cancer whose first treatment stopped working. About 66 participants will be randomly assigned to …
Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC